Global Cell Gene Therapy Biomanufacturing Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Cell and gene therapy (CGT) includes the injection of cells, genes, or gene-modified cells into a patient with the purpose of preventing or treating a disease. Cell therapy involves the injection of cells to replace or aid the repair of damaged cells, whereas gene therapy involves the injection of genes into cells to alter the genetic makeup of the recipient cells. Cell-based gene therapies, such as chimeric antigen receptor T (CAR-T) therapy, represent combinations of both approaches.
The global Cell Gene Therapy Biomanufacturing market size is projected to grow from US$ 15080 million in 2024 to US$ 28210 million in 2030; it is expected to grow at a CAGR of 11.0% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Cell Gene Therapy Biomanufacturing Industry Forecast” looks at past sales and reviews total world Cell Gene Therapy Biomanufacturing sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell Gene Therapy Biomanufacturing sales for 2023 through 2029. With Cell Gene Therapy Biomanufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Gene Therapy Biomanufacturing industry.
This Insight Report provides a comprehensive analysis of the global Cell Gene Therapy Biomanufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Gene Therapy Biomanufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Gene Therapy Biomanufacturing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Gene Therapy Biomanufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Gene Therapy Biomanufacturing.
In recent years, the demand for cell and gene therapy (CGT) has surged as the number of United States Food and Drug Administration (U.S. FDA)-approved CGT products has increased annually. This increasing demand underscores the pressing need for manufacturers to improve and advance their production processes to keep pace with the rapidly evolving CGT field. The entire CGT manufacturing process must occur in a facility that complies with good manufacturing practice (GMP) regulations and has received full authorization to manufacture CGTs or advanced-therapy medicinal products, as they are referred to in Europe, for human use. Numerous clinical trials have been conducted to assess the safety and efficacy of CGTs for a wide range of clinical indications, including cancer.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Gene Therapy Biomanufacturing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Cell and gene therapy (CGT) includes the injection of cells, genes, or gene-modified cells into a patient with the purpose of preventing or treating a disease. Cell therapy involves the injection of cells to replace or aid the repair of damaged cells, whereas gene therapy involves the injection of genes into cells to alter the genetic makeup of the recipient cells. Cell-based gene therapies, such as chimeric antigen receptor T (CAR-T) therapy, represent combinations of both approaches.
The global Cell Gene Therapy Biomanufacturing market size is projected to grow from US$ 15080 million in 2024 to US$ 28210 million in 2030; it is expected to grow at a CAGR of 11.0% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Cell Gene Therapy Biomanufacturing Industry Forecast” looks at past sales and reviews total world Cell Gene Therapy Biomanufacturing sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell Gene Therapy Biomanufacturing sales for 2023 through 2029. With Cell Gene Therapy Biomanufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Gene Therapy Biomanufacturing industry.
This Insight Report provides a comprehensive analysis of the global Cell Gene Therapy Biomanufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Gene Therapy Biomanufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Gene Therapy Biomanufacturing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Gene Therapy Biomanufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Gene Therapy Biomanufacturing.
In recent years, the demand for cell and gene therapy (CGT) has surged as the number of United States Food and Drug Administration (U.S. FDA)-approved CGT products has increased annually. This increasing demand underscores the pressing need for manufacturers to improve and advance their production processes to keep pace with the rapidly evolving CGT field. The entire CGT manufacturing process must occur in a facility that complies with good manufacturing practice (GMP) regulations and has received full authorization to manufacture CGTs or advanced-therapy medicinal products, as they are referred to in Europe, for human use. Numerous clinical trials have been conducted to assess the safety and efficacy of CGTs for a wide range of clinical indications, including cancer.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Gene Therapy Biomanufacturing market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Consumables
- Equipment
- Software Solutions
- Life Science Companies
- Contract Research Organizations
- Contract Manufacturing Organizations
- Cell Banks
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Consumables
- Equipment
- Software Solutions
- Life Science Companies
- Contract Research Organizations
- Contract Manufacturing Organizations
- Cell Banks
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonza Group
- Thermo Fisher Scientific Inc.
- Merck KGaA
- WuXi AppTec
- Catalent, Inc.
- Samsung Biologics
- FUJIFILM Diosynth Biotechnologies
- Charles River Laboratories
- Cytiva
- Novasep
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell Gene Therapy Biomanufacturing Market Size 2019-2030
2.1.2 Cell Gene Therapy Biomanufacturing Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Cell Gene Therapy Biomanufacturing by Country/Region, 2019, 2023 & 2030
2.2 Cell Gene Therapy Biomanufacturing Segment by Type
2.2.1 Consumables
2.2.2 Equipment
2.2.3 Software Solutions
2.3 Cell Gene Therapy Biomanufacturing Market Size by Type
2.3.1 Cell Gene Therapy Biomanufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
2.4 Cell Gene Therapy Biomanufacturing Segment by Application
2.4.1 Life Science Companies
2.4.2 Contract Research Organizations
2.4.3 Contract Manufacturing Organizations
2.4.4 Cell Banks
2.5 Cell Gene Therapy Biomanufacturing Market Size by Application
2.5.1 Cell Gene Therapy Biomanufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
3 CELL GENE THERAPY BIOMANUFACTURING MARKET SIZE BY PLAYER
3.1 Cell Gene Therapy Biomanufacturing Market Size Market Share by Player
3.1.1 Global Cell Gene Therapy Biomanufacturing Revenue by Player (2019-2024)
3.1.2 Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Player (2019-2024)
3.2 Global Cell Gene Therapy Biomanufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL GENE THERAPY BIOMANUFACTURING BY REGION
4.1 Cell Gene Therapy Biomanufacturing Market Size by Region (2019-2024)
4.2 Global Cell Gene Therapy Biomanufacturing Annual Revenue by Country/Region (2019-2024)
4.3 Americas Cell Gene Therapy Biomanufacturing Market Size Growth (2019-2024)
4.4 APAC Cell Gene Therapy Biomanufacturing Market Size Growth (2019-2024)
4.5 Europe Cell Gene Therapy Biomanufacturing Market Size Growth (2019-2024)
4.6 Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Cell Gene Therapy Biomanufacturing Market Size by Country (2019-2024)
5.2 Americas Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024)
5.3 Americas Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Gene Therapy Biomanufacturing Market Size by Region (2019-2024)
6.2 APAC Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024)
6.3 APAC Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell Gene Therapy Biomanufacturing Market Size by Country (2019-2024)
7.2 Europe Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024)
7.3 Europe Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell Gene Therapy Biomanufacturing by Region (2019-2024)
8.2 Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024)
8.3 Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL GENE THERAPY BIOMANUFACTURING MARKET FORECAST
10.1 Global Cell Gene Therapy Biomanufacturing Forecast by Region (2025-2030)
10.1.1 Global Cell Gene Therapy Biomanufacturing Forecast by Region (2025-2030)
10.1.2 Americas Cell Gene Therapy Biomanufacturing Forecast
10.1.3 APAC Cell Gene Therapy Biomanufacturing Forecast
10.1.4 Europe Cell Gene Therapy Biomanufacturing Forecast
10.1.5 Middle East & Africa Cell Gene Therapy Biomanufacturing Forecast
10.2 Americas Cell Gene Therapy Biomanufacturing Forecast by Country (2025-2030)
10.2.1 United States Market Cell Gene Therapy Biomanufacturing Forecast
10.2.2 Canada Market Cell Gene Therapy Biomanufacturing Forecast
10.2.3 Mexico Market Cell Gene Therapy Biomanufacturing Forecast
10.2.4 Brazil Market Cell Gene Therapy Biomanufacturing Forecast
10.3 APAC Cell Gene Therapy Biomanufacturing Forecast by Region (2025-2030)
10.3.1 China Cell Gene Therapy Biomanufacturing Market Forecast
10.3.2 Japan Market Cell Gene Therapy Biomanufacturing Forecast
10.3.3 Korea Market Cell Gene Therapy Biomanufacturing Forecast
10.3.4 Southeast Asia Market Cell Gene Therapy Biomanufacturing Forecast
10.3.5 India Market Cell Gene Therapy Biomanufacturing Forecast
10.3.6 Australia Market Cell Gene Therapy Biomanufacturing Forecast
10.4 Europe Cell Gene Therapy Biomanufacturing Forecast by Country (2025-2030)
10.4.1 Germany Market Cell Gene Therapy Biomanufacturing Forecast
10.4.2 France Market Cell Gene Therapy Biomanufacturing Forecast
10.4.3 UK Market Cell Gene Therapy Biomanufacturing Forecast
10.4.4 Italy Market Cell Gene Therapy Biomanufacturing Forecast
10.4.5 Russia Market Cell Gene Therapy Biomanufacturing Forecast
10.5 Middle East & Africa Cell Gene Therapy Biomanufacturing Forecast by Region (2025-2030)
10.5.1 Egypt Market Cell Gene Therapy Biomanufacturing Forecast
10.5.2 South Africa Market Cell Gene Therapy Biomanufacturing Forecast
10.5.3 Israel Market Cell Gene Therapy Biomanufacturing Forecast
10.5.4 Turkey Market Cell Gene Therapy Biomanufacturing Forecast
10.6 Global Cell Gene Therapy Biomanufacturing Forecast by Type (2025-2030)
10.7 Global Cell Gene Therapy Biomanufacturing Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Cell Gene Therapy Biomanufacturing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza Group
11.1.1 Lonza Group Company Information
11.1.2 Lonza Group Cell Gene Therapy Biomanufacturing Product Offered
11.1.3 Lonza Group Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Lonza Group Main Business Overview
11.1.5 Lonza Group Latest Developments
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Information
11.2.2 Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Product Offered
11.2.3 Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Scientific Inc. Main Business Overview
11.2.5 Thermo Fisher Scientific Inc. Latest Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Information
11.3.2 Merck KGaA Cell Gene Therapy Biomanufacturing Product Offered
11.3.3 Merck KGaA Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Merck KGaA Main Business Overview
11.3.5 Merck KGaA Latest Developments
11.4 WuXi AppTec
11.4.1 WuXi AppTec Company Information
11.4.2 WuXi AppTec Cell Gene Therapy Biomanufacturing Product Offered
11.4.3 WuXi AppTec Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 WuXi AppTec Main Business Overview
11.4.5 WuXi AppTec Latest Developments
11.5 Catalent, Inc.
11.5.1 Catalent, Inc. Company Information
11.5.2 Catalent, Inc. Cell Gene Therapy Biomanufacturing Product Offered
11.5.3 Catalent, Inc. Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Catalent, Inc. Main Business Overview
11.5.5 Catalent, Inc. Latest Developments
11.6 Samsung Biologics
11.6.1 Samsung Biologics Company Information
11.6.2 Samsung Biologics Cell Gene Therapy Biomanufacturing Product Offered
11.6.3 Samsung Biologics Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Samsung Biologics Main Business Overview
11.6.5 Samsung Biologics Latest Developments
11.7 FUJIFILM Diosynth Biotechnologies
11.7.1 FUJIFILM Diosynth Biotechnologies Company Information
11.7.2 FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Product Offered
11.7.3 FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.7.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.8 Charles River Laboratories
11.8.1 Charles River Laboratories Company Information
11.8.2 Charles River Laboratories Cell Gene Therapy Biomanufacturing Product Offered
11.8.3 Charles River Laboratories Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Charles River Laboratories Main Business Overview
11.8.5 Charles River Laboratories Latest Developments
11.9 Cytiva
11.9.1 Cytiva Company Information
11.9.2 Cytiva Cell Gene Therapy Biomanufacturing Product Offered
11.9.3 Cytiva Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Cytiva Main Business Overview
11.9.5 Cytiva Latest Developments
11.10 Novasep
11.10.1 Novasep Company Information
11.10.2 Novasep Cell Gene Therapy Biomanufacturing Product Offered
11.10.3 Novasep Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Novasep Main Business Overview
11.10.5 Novasep Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell Gene Therapy Biomanufacturing Market Size 2019-2030
2.1.2 Cell Gene Therapy Biomanufacturing Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Cell Gene Therapy Biomanufacturing by Country/Region, 2019, 2023 & 2030
2.2 Cell Gene Therapy Biomanufacturing Segment by Type
2.2.1 Consumables
2.2.2 Equipment
2.2.3 Software Solutions
2.3 Cell Gene Therapy Biomanufacturing Market Size by Type
2.3.1 Cell Gene Therapy Biomanufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
2.4 Cell Gene Therapy Biomanufacturing Segment by Application
2.4.1 Life Science Companies
2.4.2 Contract Research Organizations
2.4.3 Contract Manufacturing Organizations
2.4.4 Cell Banks
2.5 Cell Gene Therapy Biomanufacturing Market Size by Application
2.5.1 Cell Gene Therapy Biomanufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
3 CELL GENE THERAPY BIOMANUFACTURING MARKET SIZE BY PLAYER
3.1 Cell Gene Therapy Biomanufacturing Market Size Market Share by Player
3.1.1 Global Cell Gene Therapy Biomanufacturing Revenue by Player (2019-2024)
3.1.2 Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Player (2019-2024)
3.2 Global Cell Gene Therapy Biomanufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL GENE THERAPY BIOMANUFACTURING BY REGION
4.1 Cell Gene Therapy Biomanufacturing Market Size by Region (2019-2024)
4.2 Global Cell Gene Therapy Biomanufacturing Annual Revenue by Country/Region (2019-2024)
4.3 Americas Cell Gene Therapy Biomanufacturing Market Size Growth (2019-2024)
4.4 APAC Cell Gene Therapy Biomanufacturing Market Size Growth (2019-2024)
4.5 Europe Cell Gene Therapy Biomanufacturing Market Size Growth (2019-2024)
4.6 Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Cell Gene Therapy Biomanufacturing Market Size by Country (2019-2024)
5.2 Americas Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024)
5.3 Americas Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Gene Therapy Biomanufacturing Market Size by Region (2019-2024)
6.2 APAC Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024)
6.3 APAC Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell Gene Therapy Biomanufacturing Market Size by Country (2019-2024)
7.2 Europe Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024)
7.3 Europe Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell Gene Therapy Biomanufacturing by Region (2019-2024)
8.2 Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024)
8.3 Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL GENE THERAPY BIOMANUFACTURING MARKET FORECAST
10.1 Global Cell Gene Therapy Biomanufacturing Forecast by Region (2025-2030)
10.1.1 Global Cell Gene Therapy Biomanufacturing Forecast by Region (2025-2030)
10.1.2 Americas Cell Gene Therapy Biomanufacturing Forecast
10.1.3 APAC Cell Gene Therapy Biomanufacturing Forecast
10.1.4 Europe Cell Gene Therapy Biomanufacturing Forecast
10.1.5 Middle East & Africa Cell Gene Therapy Biomanufacturing Forecast
10.2 Americas Cell Gene Therapy Biomanufacturing Forecast by Country (2025-2030)
10.2.1 United States Market Cell Gene Therapy Biomanufacturing Forecast
10.2.2 Canada Market Cell Gene Therapy Biomanufacturing Forecast
10.2.3 Mexico Market Cell Gene Therapy Biomanufacturing Forecast
10.2.4 Brazil Market Cell Gene Therapy Biomanufacturing Forecast
10.3 APAC Cell Gene Therapy Biomanufacturing Forecast by Region (2025-2030)
10.3.1 China Cell Gene Therapy Biomanufacturing Market Forecast
10.3.2 Japan Market Cell Gene Therapy Biomanufacturing Forecast
10.3.3 Korea Market Cell Gene Therapy Biomanufacturing Forecast
10.3.4 Southeast Asia Market Cell Gene Therapy Biomanufacturing Forecast
10.3.5 India Market Cell Gene Therapy Biomanufacturing Forecast
10.3.6 Australia Market Cell Gene Therapy Biomanufacturing Forecast
10.4 Europe Cell Gene Therapy Biomanufacturing Forecast by Country (2025-2030)
10.4.1 Germany Market Cell Gene Therapy Biomanufacturing Forecast
10.4.2 France Market Cell Gene Therapy Biomanufacturing Forecast
10.4.3 UK Market Cell Gene Therapy Biomanufacturing Forecast
10.4.4 Italy Market Cell Gene Therapy Biomanufacturing Forecast
10.4.5 Russia Market Cell Gene Therapy Biomanufacturing Forecast
10.5 Middle East & Africa Cell Gene Therapy Biomanufacturing Forecast by Region (2025-2030)
10.5.1 Egypt Market Cell Gene Therapy Biomanufacturing Forecast
10.5.2 South Africa Market Cell Gene Therapy Biomanufacturing Forecast
10.5.3 Israel Market Cell Gene Therapy Biomanufacturing Forecast
10.5.4 Turkey Market Cell Gene Therapy Biomanufacturing Forecast
10.6 Global Cell Gene Therapy Biomanufacturing Forecast by Type (2025-2030)
10.7 Global Cell Gene Therapy Biomanufacturing Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Cell Gene Therapy Biomanufacturing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza Group
11.1.1 Lonza Group Company Information
11.1.2 Lonza Group Cell Gene Therapy Biomanufacturing Product Offered
11.1.3 Lonza Group Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Lonza Group Main Business Overview
11.1.5 Lonza Group Latest Developments
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Information
11.2.2 Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Product Offered
11.2.3 Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Scientific Inc. Main Business Overview
11.2.5 Thermo Fisher Scientific Inc. Latest Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Information
11.3.2 Merck KGaA Cell Gene Therapy Biomanufacturing Product Offered
11.3.3 Merck KGaA Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Merck KGaA Main Business Overview
11.3.5 Merck KGaA Latest Developments
11.4 WuXi AppTec
11.4.1 WuXi AppTec Company Information
11.4.2 WuXi AppTec Cell Gene Therapy Biomanufacturing Product Offered
11.4.3 WuXi AppTec Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 WuXi AppTec Main Business Overview
11.4.5 WuXi AppTec Latest Developments
11.5 Catalent, Inc.
11.5.1 Catalent, Inc. Company Information
11.5.2 Catalent, Inc. Cell Gene Therapy Biomanufacturing Product Offered
11.5.3 Catalent, Inc. Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Catalent, Inc. Main Business Overview
11.5.5 Catalent, Inc. Latest Developments
11.6 Samsung Biologics
11.6.1 Samsung Biologics Company Information
11.6.2 Samsung Biologics Cell Gene Therapy Biomanufacturing Product Offered
11.6.3 Samsung Biologics Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Samsung Biologics Main Business Overview
11.6.5 Samsung Biologics Latest Developments
11.7 FUJIFILM Diosynth Biotechnologies
11.7.1 FUJIFILM Diosynth Biotechnologies Company Information
11.7.2 FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Product Offered
11.7.3 FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.7.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.8 Charles River Laboratories
11.8.1 Charles River Laboratories Company Information
11.8.2 Charles River Laboratories Cell Gene Therapy Biomanufacturing Product Offered
11.8.3 Charles River Laboratories Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Charles River Laboratories Main Business Overview
11.8.5 Charles River Laboratories Latest Developments
11.9 Cytiva
11.9.1 Cytiva Company Information
11.9.2 Cytiva Cell Gene Therapy Biomanufacturing Product Offered
11.9.3 Cytiva Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Cytiva Main Business Overview
11.9.5 Cytiva Latest Developments
11.10 Novasep
11.10.1 Novasep Company Information
11.10.2 Novasep Cell Gene Therapy Biomanufacturing Product Offered
11.10.3 Novasep Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Novasep Main Business Overview
11.10.5 Novasep Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cell Gene Therapy Biomanufacturing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Cell Gene Therapy Biomanufacturing Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Consumables
Table 4. Major Players of Equipment
Table 5. Major Players of Software Solutions
Table 6. Cell Gene Therapy Biomanufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 8. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Table 9. Cell Gene Therapy Biomanufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 11. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Table 12. Global Cell Gene Therapy Biomanufacturing Revenue by Player (2019-2024) & ($ millions)
Table 13. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Player (2019-2024)
Table 14. Cell Gene Therapy Biomanufacturing Key Players Head office and Products Offered
Table 15. Cell Gene Therapy Biomanufacturing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Cell Gene Therapy Biomanufacturing Market Size by Region (2019-2024) & ($ millions)
Table 19. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Region (2019-2024)
Table 20. Global Cell Gene Therapy Biomanufacturing Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Cell Gene Therapy Biomanufacturing Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas Cell Gene Therapy Biomanufacturing Market Size Market Share by Country (2019-2024)
Table 24. Americas Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Table 26. Americas Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Table 28. APAC Cell Gene Therapy Biomanufacturing Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC Cell Gene Therapy Biomanufacturing Market Size Market Share by Region (2019-2024)
Table 30. APAC Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe Cell Gene Therapy Biomanufacturing Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe Cell Gene Therapy Biomanufacturing Market Size Market Share by Country (2019-2024)
Table 34. Europe Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Cell Gene Therapy Biomanufacturing
Table 40. Key Market Challenges & Risks of Cell Gene Therapy Biomanufacturing
Table 41. Key Industry Trends of Cell Gene Therapy Biomanufacturing
Table 42. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global Cell Gene Therapy Biomanufacturing Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. Lonza Group Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 47. Lonza Group Cell Gene Therapy Biomanufacturing Product Offered
Table 48. Lonza Group Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Lonza Group Main Business
Table 50. Lonza Group Latest Developments
Table 51. Thermo Fisher Scientific Inc. Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 52. Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Product Offered
Table 53. Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Thermo Fisher Scientific Inc. Main Business
Table 55. Thermo Fisher Scientific Inc. Latest Developments
Table 56. Merck KGaA Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 57. Merck KGaA Cell Gene Therapy Biomanufacturing Product Offered
Table 58. Merck KGaA Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Merck KGaA Main Business
Table 60. Merck KGaA Latest Developments
Table 61. WuXi AppTec Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 62. WuXi AppTec Cell Gene Therapy Biomanufacturing Product Offered
Table 63. WuXi AppTec Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. WuXi AppTec Main Business
Table 65. WuXi AppTec Latest Developments
Table 66. Catalent, Inc. Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 67. Catalent, Inc. Cell Gene Therapy Biomanufacturing Product Offered
Table 68. Catalent, Inc. Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Catalent, Inc. Main Business
Table 70. Catalent, Inc. Latest Developments
Table 71. Samsung Biologics Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 72. Samsung Biologics Cell Gene Therapy Biomanufacturing Product Offered
Table 73. Samsung Biologics Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Samsung Biologics Main Business
Table 75. Samsung Biologics Latest Developments
Table 76. FUJIFILM Diosynth Biotechnologies Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 77. FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Product Offered
Table 78. FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. FUJIFILM Diosynth Biotechnologies Main Business
Table 80. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 81. Charles River Laboratories Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 82. Charles River Laboratories Cell Gene Therapy Biomanufacturing Product Offered
Table 83. Charles River Laboratories Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Charles River Laboratories Main Business
Table 85. Charles River Laboratories Latest Developments
Table 86. Cytiva Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 87. Cytiva Cell Gene Therapy Biomanufacturing Product Offered
Table 88. Cytiva Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Cytiva Main Business
Table 90. Cytiva Latest Developments
Table 91. Novasep Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 92. Novasep Cell Gene Therapy Biomanufacturing Product Offered
Table 93. Novasep Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Novasep Main Business
Table 95. Novasep Latest Developments
Table 1. Cell Gene Therapy Biomanufacturing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Cell Gene Therapy Biomanufacturing Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Consumables
Table 4. Major Players of Equipment
Table 5. Major Players of Software Solutions
Table 6. Cell Gene Therapy Biomanufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 8. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Table 9. Cell Gene Therapy Biomanufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 11. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Table 12. Global Cell Gene Therapy Biomanufacturing Revenue by Player (2019-2024) & ($ millions)
Table 13. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Player (2019-2024)
Table 14. Cell Gene Therapy Biomanufacturing Key Players Head office and Products Offered
Table 15. Cell Gene Therapy Biomanufacturing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Cell Gene Therapy Biomanufacturing Market Size by Region (2019-2024) & ($ millions)
Table 19. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Region (2019-2024)
Table 20. Global Cell Gene Therapy Biomanufacturing Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Cell Gene Therapy Biomanufacturing Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas Cell Gene Therapy Biomanufacturing Market Size Market Share by Country (2019-2024)
Table 24. Americas Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Table 26. Americas Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Table 28. APAC Cell Gene Therapy Biomanufacturing Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC Cell Gene Therapy Biomanufacturing Market Size Market Share by Region (2019-2024)
Table 30. APAC Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe Cell Gene Therapy Biomanufacturing Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe Cell Gene Therapy Biomanufacturing Market Size Market Share by Country (2019-2024)
Table 34. Europe Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Cell Gene Therapy Biomanufacturing
Table 40. Key Market Challenges & Risks of Cell Gene Therapy Biomanufacturing
Table 41. Key Industry Trends of Cell Gene Therapy Biomanufacturing
Table 42. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global Cell Gene Therapy Biomanufacturing Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. Lonza Group Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 47. Lonza Group Cell Gene Therapy Biomanufacturing Product Offered
Table 48. Lonza Group Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Lonza Group Main Business
Table 50. Lonza Group Latest Developments
Table 51. Thermo Fisher Scientific Inc. Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 52. Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Product Offered
Table 53. Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Thermo Fisher Scientific Inc. Main Business
Table 55. Thermo Fisher Scientific Inc. Latest Developments
Table 56. Merck KGaA Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 57. Merck KGaA Cell Gene Therapy Biomanufacturing Product Offered
Table 58. Merck KGaA Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Merck KGaA Main Business
Table 60. Merck KGaA Latest Developments
Table 61. WuXi AppTec Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 62. WuXi AppTec Cell Gene Therapy Biomanufacturing Product Offered
Table 63. WuXi AppTec Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. WuXi AppTec Main Business
Table 65. WuXi AppTec Latest Developments
Table 66. Catalent, Inc. Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 67. Catalent, Inc. Cell Gene Therapy Biomanufacturing Product Offered
Table 68. Catalent, Inc. Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Catalent, Inc. Main Business
Table 70. Catalent, Inc. Latest Developments
Table 71. Samsung Biologics Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 72. Samsung Biologics Cell Gene Therapy Biomanufacturing Product Offered
Table 73. Samsung Biologics Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Samsung Biologics Main Business
Table 75. Samsung Biologics Latest Developments
Table 76. FUJIFILM Diosynth Biotechnologies Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 77. FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Product Offered
Table 78. FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. FUJIFILM Diosynth Biotechnologies Main Business
Table 80. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 81. Charles River Laboratories Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 82. Charles River Laboratories Cell Gene Therapy Biomanufacturing Product Offered
Table 83. Charles River Laboratories Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Charles River Laboratories Main Business
Table 85. Charles River Laboratories Latest Developments
Table 86. Cytiva Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 87. Cytiva Cell Gene Therapy Biomanufacturing Product Offered
Table 88. Cytiva Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Cytiva Main Business
Table 90. Cytiva Latest Developments
Table 91. Novasep Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 92. Novasep Cell Gene Therapy Biomanufacturing Product Offered
Table 93. Novasep Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Novasep Main Business
Table 95. Novasep Latest Developments
LIST OF FIGURES
Figure 1. Cell Gene Therapy Biomanufacturing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell Gene Therapy Biomanufacturing Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Cell Gene Therapy Biomanufacturing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Cell Gene Therapy Biomanufacturing Sales Market Share by Country/Region (2023)
Figure 8. Cell Gene Therapy Biomanufacturing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Type in 2023
Figure 10. Cell Gene Therapy Biomanufacturing in Life Science Companies
Figure 11. Global Cell Gene Therapy Biomanufacturing Market: Life Science Companies (2019-2024) & ($ millions)
Figure 12. Cell Gene Therapy Biomanufacturing in Contract Research Organizations
Figure 13. Global Cell Gene Therapy Biomanufacturing Market: Contract Research Organizations (2019-2024) & ($ millions)
Figure 14. Cell Gene Therapy Biomanufacturing in Contract Manufacturing Organizations
Figure 15. Global Cell Gene Therapy Biomanufacturing Market: Contract Manufacturing Organizations (2019-2024) & ($ millions)
Figure 16. Cell Gene Therapy Biomanufacturing in Cell Banks
Figure 17. Global Cell Gene Therapy Biomanufacturing Market: Cell Banks (2019-2024) & ($ millions)
Figure 18. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Application in 2023
Figure 19. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Player in 2023
Figure 20. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Region (2019-2024)
Figure 21. Americas Cell Gene Therapy Biomanufacturing Market Size 2019-2024 ($ millions)
Figure 22. APAC Cell Gene Therapy Biomanufacturing Market Size 2019-2024 ($ millions)
Figure 23. Europe Cell Gene Therapy Biomanufacturing Market Size 2019-2024 ($ millions)
Figure 24. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size 2019-2024 ($ millions)
Figure 25. Americas Cell Gene Therapy Biomanufacturing Value Market Share by Country in 2023
Figure 26. United States Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 27. Canada Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 28. Mexico Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 29. Brazil Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 30. APAC Cell Gene Therapy Biomanufacturing Market Size Market Share by Region in 2023
Figure 31. APAC Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Figure 32. APAC Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Figure 33. China Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 34. Japan Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 35. South Korea Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 36. Southeast Asia Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 37. India Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 38. Australia Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 39. Europe Cell Gene Therapy Biomanufacturing Market Size Market Share by Country in 2023
Figure 40. Europe Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Figure 41. Europe Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Figure 42. Germany Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 43. France Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 44. UK Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 45. Italy Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 46. Russia Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 47. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 51. South Africa Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 52. Israel Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 53. Turkey Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 54. GCC Countries Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 55. Americas Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 56. APAC Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 57. Europe Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 58. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 59. United States Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 60. Canada Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 61. Mexico Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 62. Brazil Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 63. China Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 64. Japan Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 65. Korea Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 66. Southeast Asia Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 67. India Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 68. Australia Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 69. Germany Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 70. France Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 71. UK Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 72. Italy Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 73. Russia Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 74. Egypt Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 75. South Africa Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 76. Israel Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 77. Turkey Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 78. GCC Countries Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 79. Global Cell Gene Therapy Biomanufacturing Market Size Market Share Forecast by Type (2025-2030)
Figure 80. Global Cell Gene Therapy Biomanufacturing Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Cell Gene Therapy Biomanufacturing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell Gene Therapy Biomanufacturing Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Cell Gene Therapy Biomanufacturing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Cell Gene Therapy Biomanufacturing Sales Market Share by Country/Region (2023)
Figure 8. Cell Gene Therapy Biomanufacturing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Type in 2023
Figure 10. Cell Gene Therapy Biomanufacturing in Life Science Companies
Figure 11. Global Cell Gene Therapy Biomanufacturing Market: Life Science Companies (2019-2024) & ($ millions)
Figure 12. Cell Gene Therapy Biomanufacturing in Contract Research Organizations
Figure 13. Global Cell Gene Therapy Biomanufacturing Market: Contract Research Organizations (2019-2024) & ($ millions)
Figure 14. Cell Gene Therapy Biomanufacturing in Contract Manufacturing Organizations
Figure 15. Global Cell Gene Therapy Biomanufacturing Market: Contract Manufacturing Organizations (2019-2024) & ($ millions)
Figure 16. Cell Gene Therapy Biomanufacturing in Cell Banks
Figure 17. Global Cell Gene Therapy Biomanufacturing Market: Cell Banks (2019-2024) & ($ millions)
Figure 18. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Application in 2023
Figure 19. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Player in 2023
Figure 20. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Region (2019-2024)
Figure 21. Americas Cell Gene Therapy Biomanufacturing Market Size 2019-2024 ($ millions)
Figure 22. APAC Cell Gene Therapy Biomanufacturing Market Size 2019-2024 ($ millions)
Figure 23. Europe Cell Gene Therapy Biomanufacturing Market Size 2019-2024 ($ millions)
Figure 24. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size 2019-2024 ($ millions)
Figure 25. Americas Cell Gene Therapy Biomanufacturing Value Market Share by Country in 2023
Figure 26. United States Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 27. Canada Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 28. Mexico Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 29. Brazil Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 30. APAC Cell Gene Therapy Biomanufacturing Market Size Market Share by Region in 2023
Figure 31. APAC Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Figure 32. APAC Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Figure 33. China Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 34. Japan Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 35. South Korea Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 36. Southeast Asia Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 37. India Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 38. Australia Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 39. Europe Cell Gene Therapy Biomanufacturing Market Size Market Share by Country in 2023
Figure 40. Europe Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Figure 41. Europe Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Figure 42. Germany Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 43. France Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 44. UK Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 45. Italy Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 46. Russia Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 47. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 51. South Africa Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 52. Israel Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 53. Turkey Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 54. GCC Countries Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 55. Americas Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 56. APAC Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 57. Europe Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 58. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 59. United States Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 60. Canada Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 61. Mexico Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 62. Brazil Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 63. China Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 64. Japan Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 65. Korea Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 66. Southeast Asia Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 67. India Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 68. Australia Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 69. Germany Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 70. France Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 71. UK Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 72. Italy Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 73. Russia Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 74. Egypt Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 75. South Africa Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 76. Israel Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 77. Turkey Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 78. GCC Countries Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 79. Global Cell Gene Therapy Biomanufacturing Market Size Market Share Forecast by Type (2025-2030)
Figure 80. Global Cell Gene Therapy Biomanufacturing Market Size Market Share Forecast by Application (2025-2030)
